HLA-G/ILT2 signaling on the path to tolerance
- 13 March 2022
- journal article
- editorial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (6) , 852-853
Abstract
No abstract availableFunding Information
- NHLBI
- VHA Office of Research & Development
This publication has 9 references indexed in Scilit:
- Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-GThe Journal of Heart and Lung Transplantation, 2022
- Towards tolerance in liver transplantationBest Practice & Research Clinical Gastroenterology, 2021
- Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortalityEuropean Respiratory Journal, 2019
- HLA-G: At the Interface of Maternal–Fetal ToleranceTrends in Immunology, 2017
- Role of HLA-G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective StudyAmerican Journal of Transplantation, 2014
- Soluble total human leukocyte antigen class I and human leukocyte antigen–G molecules in kidney and kidney/pancreas transplantationHuman Immunology, 2009
- Immunohistochemical Study of HLA-G Expression in Lung Transplant RecipientsAmerican Journal of Transplantation, 2009
- HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cellsThe FASEB Journal, 2005
- Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantationJournal of Hepatology, 2003